| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/09/2011 | EP2292613A1 Dihydroindolinone derivatives |
| 03/09/2011 | EP2292611A1 Novel thiophenediamine derivative having urea structure |
| 03/09/2011 | EP2292596A2 CETP activity inhibitor |
| 03/09/2011 | EP2292595A1 Potassium channel modulators |
| 03/09/2011 | EP2292280A1 Medical devices containing rapamycin analogs |
| 03/09/2011 | EP2292242A1 A scutellarin derivative, the preparing process, the pharmaceutical composition and the use thereof |
| 03/09/2011 | EP2292241A1 A scutellarin derivative, the preparing process, the pharmaceutical composition and the use thereof |
| 03/09/2011 | EP2292234A1 Compositions comprising quinazoline derivatives, preparation methods and uses thereof |
| 03/09/2011 | EP2292233A2 Pharmaceutical uses of N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine |
| 03/09/2011 | EP2292232A1 Beta-amino tetrahydroimidazo(1,2-A)pyrazines and tetrahydrotriazolo(4,3-A)pyrazines for use in the treatment of diabetes type II |
| 03/09/2011 | EP2292225A1 Dosage form comprising taxol in crystalline form |
| 03/09/2011 | EP2292211A2 Mucoadhesive pharmaceutical formulations |
| 03/09/2011 | EP2292091A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
| 03/09/2011 | EP2291522A1 Herg mutants and uses thereof |
| 03/09/2011 | EP2291183A2 Use of dronedarone for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level due to dronedarone administration |
| 03/09/2011 | EP2034999B9 Dha esters and use thereof in the treatment and the prevention of cardiovascular diseases |
| 03/09/2011 | EP1838840B1 Use of cultured three-dimensional tissue for treating congestive heart failure |
| 03/09/2011 | EP1830887B1 Antithrombotic dual inhibitors comprising a biotin residue |
| 03/09/2011 | EP1641795B1 Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals |
| 03/09/2011 | EP1585730B1 Carboxamide derivatives and their use as factor xa inhibitors |
| 03/09/2011 | EP1497279B1 Substituted indoles and their use as 5ht-reuptake inhibitors and as 5ht ligands |
| 03/09/2011 | EP1315513B1 "pseudo"-native chemical ligation |
| 03/09/2011 | CN1582274B Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 03/09/2011 | CN101984759A Modulation of factor 9 expression |
| 03/09/2011 | CN101984034A Health-care wine |
| 03/09/2011 | CN101983714A Traditional Chinese medicine composition for treating angina and preparation method thereof |
| 03/09/2011 | CN101983712A Novel medicament for treating coronary heart disease |
| 03/09/2011 | CN101983705A Traditional Chinese medicine for treating diabetic acra necrosis |
| 03/09/2011 | CN101983704A Traditional Chinese medicine for treating diabetic foot |
| 03/09/2011 | CN101983698A Traditional Chinese medicine composition for treating rheumatic heart disease and preparation method thereof |
| 03/09/2011 | CN101983695A Traditional Chinese medicine composition for curing hemiplegia and preparation method thereof |
| 03/09/2011 | CN101983694A Traditional Chinese medicine for treating cerebral haemorrhage |
| 03/09/2011 | CN101983687A Traditional Chinese medicine for supplementing qi and removing blood stasis and preparation method thereof |
| 03/09/2011 | CN101983659A Traditional Chinese medicine composition for treating hypertension and preparation method thereof |
| 03/09/2011 | CN101983657A Traditional Chinese medicine for treating diabetic retinopathy |
| 03/09/2011 | CN101983644A Medicament for treating sequelae of apoplexy |
| 03/09/2011 | CN101983641A Medicament for treating thromboangiitis obliterans |
| 03/09/2011 | CN101983640A Traditional Chinese medicine for treating diabetic heart disease |
| 03/09/2011 | CN101983638A Traditional Chinese medicine for treating diabetic coronary heart disease |
| 03/09/2011 | CN101983637A Radix trichosanthis saponin and application of radix trichosanthis saponin in preparing medicine for treating ischemic cerebrovascular diseases |
| 03/09/2011 | CN101983636A Safflower granules and preparation method thereof |
| 03/09/2011 | CN101983624A Zusanli massage health promotion stripe |
| 03/09/2011 | CN101497614B 1,2,3,5,11,11a- hexahydro-3,3-dimethyl-1-oxo-6H-glyoxaline [3', 4': 1,2] pyridine [3,4-b] diindyl-2-substituted methyl acetate, as well as preparation and application thereof |
| 03/09/2011 | CN101417086B Traditional Chinese medicine preparation for treating myocardial ischemia |
| 03/09/2011 | CN101297969B Combinations of the peroxisome proliferator-activated receptor (PPAR) activator fenofibrate with sterol absorption inhibitor ezetimibe for vascular indications |
| 03/09/2011 | CN101068560B Method of screening toxin-neutralizing peptide, STX2 inhibitory peptide and Vero toxin-neutralizing agent |
| 03/08/2011 | US7902399 Fatty acids analogous |
| 03/08/2011 | US7902378 Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment |
| 03/08/2011 | US7902369 Diaryl-substituted five-membered heterocycle derivative |
| 03/08/2011 | US7902366 NK1 antagonists |
| 03/08/2011 | US7902360 e.g. 3-[2-(4-aminophenyl)ethyl]-8-benzyl-7-(2-ethylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility |
| 03/08/2011 | US7902261 Use of fingolimod or salt |
| 03/08/2011 | US7902250 Compositions based on aminoacids, suitable for the treatment of heart failure |
| 03/08/2011 | US7902223 Phenyl derivatives as factor XA inhibitors |
| 03/08/2011 | US7902176 Etherified oxidized phospholipids for inducing tolerance to oxidized LDL via mucosal administration; 1-hexadecyl-2-(5'-oxo-pentanyl)-sn-glycero-3-phosphocholine (D-ALLE) |
| 03/08/2011 | US7902149 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins |
| 03/08/2011 | US7901917 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 03/08/2011 | US7901879 Also stimulating interleukin-18 or GM-CSF by administering lactoferrin |
| 03/08/2011 | US7901682 Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation |
| 03/08/2011 | US7901672 Methods of making enhanced, autologous fat grafts |
| 03/08/2011 | CA2571644C New association of a sinus node if current inhibitor and a converting enzyme inhibitor, and the pharmaceutical compositions containing them |
| 03/08/2011 | CA2464721C Nitrogenous (tetrahydropyridyl) (alkyl) heterocycles with tnf activity |
| 03/08/2011 | CA2460313C Bisphenylsulfanyl and sulphonate compounds and use thereof for elevating hdl cholesterol levels |
| 03/08/2011 | CA2432126C Complex of modafinil and cyclodextrin |
| 03/08/2011 | CA2415396C 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 03/08/2011 | CA2137377C Retinal pigmented epithelium derived neurotrophic factor |
| 03/03/2011 | WO2011026153A2 Inotilone derivatives as coherent biological response modifier (cbmr) |
| 03/03/2011 | WO2011026041A2 Sdf-1 delivery for treating ischemic tissue |
| 03/03/2011 | WO2011026015A2 Stabilized melanocortin ligands |
| 03/03/2011 | WO2011025883A2 Natural igm antibodies |
| 03/03/2011 | WO2011024987A1 Aromatic fused heterocyclic derivative and pharmaceutical composition containing same |
| 03/03/2011 | WO2011024955A1 Nucleic acid capable of binding to tgf-βii-type receptor, and use thereof |
| 03/03/2011 | WO2011024933A1 3-(biaryloxy) propionic acid derivative |
| 03/03/2011 | WO2011024932A1 Novel tetrahydroisoquinoline compounds |
| 03/03/2011 | WO2011024918A1 Antiangiogenic agent and method for inhibition of angiogenesis |
| 03/03/2011 | WO2011024874A1 Base addition salts |
| 03/03/2011 | WO2011024480A1 Drug composition for angiogenesis therapy |
| 03/03/2011 | WO2011024468A1 Novel sulfonamide derivative and pharmaceutical product containing same |
| 03/03/2011 | WO2011024156A1 Isotopically labeled neurochemical agents and uses thereof for diagnosing conditions and disorders |
| 03/03/2011 | WO2011024154A1 Use of irbesartan for the preparation of a medicament for the prevention of hospitalization for heart failure. |
| 03/03/2011 | WO2011023812A1 Microsomal prostaglandin e synthase-1 (mpges1) inhibitors |
| 03/03/2011 | WO2011023703A1 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof |
| 03/03/2011 | WO2010142805A4 New potent anti apob antisense compounds |
| 03/03/2011 | WO2010117233A3 Stable pharmaceutical composition containing fluvastatin and method for manufacturing the same |
| 03/03/2011 | WO2010091362A3 Topical formulations comprising ion channel modulators |
| 03/03/2011 | WO2010091234A9 Methods of treating vascular lesions |
| 03/03/2011 | WO2008065408A9 Modulation of prostaglandin/cyclooxygenase metabolic pathways |
| 03/03/2011 | WO2008053362A3 Bioresponsive polymers |
| 03/03/2011 | US20110055942 Single domain TDF-related compounds and analogs thereof |
| 03/03/2011 | US20110055940 Therapeutic Inhibitors of PAI-1 Function Methods of Their Use |
| 03/03/2011 | US20110054237 Methods and Systems for Magnetic Focusing of Therapeutic, Diagnostic or Prophylactic Agents to Deep Targets |
| 03/03/2011 | US20110054043 Film composition |
| 03/03/2011 | US20110054033 Methods of using abscisic acid for ameliorating hypertension and vascular inflammation |
| 03/03/2011 | US20110054032 Dioxoanthracene sulphonate derivatives |
| 03/03/2011 | US20110054029 Water-soluble dietary fatty acids |
| 03/03/2011 | US20110054018 Inotilone derivatives as coherent biological response modifier (cBMR) |
| 03/03/2011 | US20110053999 4-methylpyrazole formulations for inhibiting ethanol intolerance |
| 03/03/2011 | US20110053997 Salts and Crystal Forms |
| 03/03/2011 | US20110053995 Benzenesulfonanilide compound inhibitors of urea transporters |
| 03/03/2011 | US20110053990 Fatty acid niacin conjugates and their uses |